Saygili Erol, Rana Obaida R, Saygili Esra, Reuter Hannes, Frank Konrad, Schwinger Robert H G, Müller-Ehmsen Jochen, Zobel Carsten
Laboratory of Muscle Research and Molecular Cardiology, Department of Internal Medicine III, University of Cologne, Kerpenerstr. 62, 50924 Cologne, Germany.
Am J Physiol Heart Circ Physiol. 2007 Jun;292(6):H2898-905. doi: 10.1152/ajpheart.00546.2006. Epub 2007 Feb 9.
Atrial fibrillation (AF) is the most frequent arrhythmia found in clinical practice. In recent studies, a decrease in the development or recurrence of AF was found in hypertensive patients treated with angiotensin-converting enzyme inhibitors or angiotensin receptor-blocking agents. Hypertension is related to an increased wall tension in the atria, resulting in increased stretch of the individual myocyte, which is one of the major stimuli for the remodeling process. In the present study, we used a model of cultured atrial neonatal rat cardiomyocytes under conditions of stretch to provide insight into the mechanisms of the preventive effect of the angiotensin receptor-blocking agent losartan against AF on a molecular level. Stretch significantly increased protein-to-DNA ratio and atrial natriuretic factor mRNA expression, indicating hypertrophy. Expression of genes encoding for the inward rectifier K(+) current (I(K1)), Kir 2.1, and Kir 2.3, as well as the gene encoding for the ultrarapid delayed rectifier K(+) current (I(Kur)), Kv 1.5, was significantly increased. In contrast, mRNA expression of Kv 4.2 was significantly reduced in stretched myocytes. Alterations of gene expression correlated with the corresponding current densities: I(K1) and I(Kur) densities were significantly increased in stretched myocytes, whereas transient outward K(+) current (I(to)) density was reduced. These alterations resulted in a significant abbreviation of the action potential duration. Losartan (1 microM) prevented stretch-induced increases in the protein-to-DNA ratio and atrial natriuretic peptide mRNA expression in stretched myocytes. Concomitantly, losartan attenuated stretch-induced alterations in I(K1), I(Kur), and I(to) density and gene expression. This prevented the stretch-induced abbreviation of action potential duration. Prevention of stretch-induced electrical remodeling might contribute to the clinical effects of losartan against AF.
心房颤动(AF)是临床实践中最常见的心律失常。在最近的研究中,发现使用血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂治疗的高血压患者发生AF或AF复发的情况减少。高血压与心房壁张力增加有关,导致单个心肌细胞的拉伸增加,这是重塑过程的主要刺激因素之一。在本研究中,我们使用了拉伸条件下培养的新生大鼠心房心肌细胞模型,以在分子水平上深入了解血管紧张素受体阻滞剂氯沙坦对AF的预防作用机制。拉伸显著增加了蛋白质与DNA的比率以及心房利钠因子mRNA的表达,表明出现肥大。内向整流钾电流(I(K1))、Kir 2.1和Kir 2.3的编码基因以及超快速延迟整流钾电流(I(Kur))、Kv 1.5的编码基因的表达均显著增加。相比之下,拉伸心肌细胞中Kv 4.2的mRNA表达显著降低。基因表达的改变与相应的电流密度相关:拉伸心肌细胞中I(K1)和I(Kur)密度显著增加,而瞬时外向钾电流(I(to))密度降低。这些改变导致动作电位时程显著缩短。氯沙坦(1 microM)可防止拉伸诱导的拉伸心肌细胞中蛋白质与DNA比率增加以及心房利钠肽mRNA表达增加。同时,氯沙坦减弱了拉伸诱导的I(K1)、I(Kur)和I(to)密度及基因表达的改变。这防止了拉伸诱导的动作电位时程缩短。预防拉伸诱导的电重塑可能有助于氯沙坦对AF的临床疗效。